The US FDA is extending the fight against opioid abuse outside the opioid drug class and investigating abuse and misuse of gabapentinoids, which have been recommended as an alternative treatment for pain.
Commissioner Scott Gottlieb told attendees of a recent meeting on safe use and appropriate opioid prescribing that doctors may be...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?